Advances in unrelated donor hematopoietic cell transplantation

Haematologica

Volumn 88, Issue 3, 2003, Pages 246-249

  Anasetti, Claudio ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLELE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CONFERENCE PAPER; DONOR; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HLA TYPING; HUMAN; SAFETY;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0037347562     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz MM, et al. Impact of HLA-Class I and Class II high resolution matching on outcome of unrelated donor BMT, Blood 2001;98:813[abstract].
2. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92:3515-20.
3. Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001;345:1794-800.
4. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998;338:962-8.
5. Maris M, Niederwieser D, Sandmaier S. Nonmyeloablative Hematopoietic Stem Cell Transplants using 10/10 HLA antigen matched unrelated donors for patients with advanced hematological malignancies ineligible for conventional regimens. Blood 2001;98:858[abstract].
6. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 89:4226-35, 1997.
7. Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000;26:397-404.
8. Anasetti C, Heimfeld S, Rowley S, Martin PJ, Petersdorf EW, Woolfrey A, et al. Higher CD34 cell dose is associated with improved survival after marrow transplantation from unrelated donors. Blood 1999;94:561[abstract].
9. Anasetti C, Haagenson M, Kollman C. Transplantation of GCSF-mobilized blood stem cells from unrelated donors. Blood 2001;98:858[abstract].
10. Bacigalupo A, Frassoni F, Van Lint MT. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation. Haematologica 2002;87(8 Suppl):4-8.
11. Aversa F. Full haplotype mismatched hematopoietic stem cell transplants. Haematologica 2002;87(8 Suppl):9-12.
12. Fagioli F, Ricchiardi A, Carnevale-Schianca F. Non-myeloablative allogeneic hematopoietic stem cell transplants. Haematologica 2002;87(8 Suppl):13-9.
13. Messina C, Cesaro S, Pillon M, Gazzola MV, Destro R, Calore E, et al. Haemaatopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: a pediatric single center experience. Haematologica 2002;87(8 Suppl):20-3.
14. Pession A, Rondelli R, Locatelli F, Dini G, Fagioli F, Messina C, et al. Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Haematologica 2002;87(8 Suppl):42-6.
15. Marmont AM. Historical perspectives, rationale and future directions for hematopoietic stem cell transplantation for severe autoimmune diseases. Haematologica 2002;87(8 Suppl):24-7.
16. De Silvestro G, Marson P, Cesaro S, Messina C. Legislative and ethical aspects of administering granulocyte colony stimulating factor to normal donors. Haematologica 2002; 87(8 Suppl):28-34.
17. Cesaro S, Marson P, Gazzola MV, De Silvestro G, Destro R, Pillon M, et al. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Haematologica 2002;87(8 Suppl):35-41.
18. Pession A, Rondelli R, Locatelli F, Dini G, Fagioli F, Messina C, et al. Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Haematologica 2002;87(8 Suppl):42-6.
19. Uderzo C, Balduzzi A. Allogeneic bone marrow transplantation versus chemotherapy in childhood very high risk acute lymphoblastic leukemia in first complete remission: a controversial issue. Haematologica 2002;87(8 Suppl):47-50.
20. Dini G, Cancedda R, Giorgiani G, Porta F, Messina C, Uderzo C, et al. on behalf of the AIEOP and the GITMO. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO). Haematologica 2002;87(8 Suppl):51-7.
21. La Nasa G, Giardini C, Locatelli F, Argiolu F, Vassallo E, Prete A, et al. Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO). Haematologica 2002;87(8 Suppl):58-61.
22. Lemoli RM, Curti A, Fogli M, Ferri E, Baccarani M. The therapeutic role of dendritic cells in cancer immunotherapy. Haematologica 2002;87(8 Suppl):58-61.